Financial Year |
March 31 2023 |
Monetary Funds |
63,070,435.22 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
3,129,760.00 |
Accounts Receivable |
9,298,354.97 |
Advances to Suppliers |
4,042,683.30 |
Other Receivables |
1,140,494.71 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
70,535,218.84 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,377,547.21 |
Total Current Assets |
157,362,471.45 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
27,034,650.20 |
Investment Properties |
-- |
Fixed Assetes |
100,778,019.54 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
20,593,116.03 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
3,280,250.35 |
Deferred Income Tax Assets |
8,020,757.23 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
160,148,848.96 |
Total Assets |
317,511,320.41 |
Short-Term Loans |
48,940,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
11,464,414.07 |
Accounts Payable |
25,776,672.92 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
9,893,556.86 |
Taxes Payable |
2,105,195.71 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,776,085.67 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
275,250.67 |
Other Current Liabilities |
3,760,372.84 |
Sub-Total of Current Liabilities |
111,842,416.78 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
420,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
937,261.95 |
Total Liabilities |
112,779,678.73 |
Paid-In Capital(Or Share Stock) |
492,089,200.00 |
Capital Surplus |
151,261,859.89 |
Surplus Reserve |
41,397,414.63 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-478,830,800.35 |
Minority Stockholder's Interest |
-1,186,032.49 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
205,917,674.17 |
Owner's Equity(Stockholder's Equity) |
204,731,641.68 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
317,511,320.41 |